SCHEMBL31229697

SCHEMBL31229697

Cc1ccc(-c2cc3[nH]c(=O)c(C(=O)O)cc3s2)cc1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 1/20 0.43
KDM4E B2RXH2 2/20 0.43
GAA P10253 2/20 0.43
HPGD P15428 1/20 0.43
HSD17B10 Q99714 1/20 0.43
GRIK1 P39086 3/20 0.40
GRIA1 P42261 2/20 0.40
GRIA2 P42262 2/20 0.40
GRIA3 P42263 2/20 0.40
GRIA4 P48058 2/20 0.40
ALDH1A1 P00352 1/20 0.39
POLB P06746 1/20 0.39
RXRB P28702 2/20 0.38
RXRA P19793 1/20 0.37
ALPL P05186 1/20 0.37
CA9 Q16790 1/20 0.37
GRIK2 Q13002 2/20 0.36
GRIK3 Q13003 2/20 0.36
UCHL1 P09936 5/20 0.36
MPL P40238 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31229731 0.85 ALDH1A1 (0.48) KDM4EGAAHPGDHSD17B10ALDH1A1
SCHEMBL31229776 0.82 ALDH1A1 (0.49) KDM4EGAAHPGDALDH1A1POLB
SCHEMBL31229566 0.76 LMNA (0.39) KDM4EALDH1A1POLBHSD17B1HSD17B2
SCHEMBL31229592 0.72 ALDH1A1 (0.58) KDM4EGAAHPGDHSD17B10ALDH1A1
SCHEMBL31229802 0.72 HSD17B10 (0.46) KDM4EGAAHPGDHSD17B10ALDH1A1
SCHEMBL25148578 0.71 KDM4E (0.61) MCL1KDM4EGAAHPGDHSD17B10
SCHEMBL31547667 0.71 KDM4E (0.61) MCL1KDM4EGAAHPGDHSD17B10
SCHEMBL31229651 0.70 KDM4E (0.42) KDM4EGAAHPGDHSD17B10GRIK1
SCHEMBL31229599 0.70 KDM4E (0.42) KDM4EGAAHPGDHSD17B10GRIK1
SCHEMBL31229575 0.69 KDM4E (0.41) KDM4EGAAHPGDHSD17B10GRIK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024222866-A1 CYCLIC DERIVATIVES, COMPOSITIONS AND USES THEREOF DANATLAS PHARMACEUTICALS CO., LTD. (CN) 2024-10-31 WO disclosed